Literature DB >> 8661486

An ultrastructural and immunogold localization study of proteoglycans associated with the osteocytes of fetal bone in osteogenesis imperfecta.

P Sarathchandra1, F M Pope, S Y Ali.   

Abstract

Osteogenesis imperfecta (OI) is a rare, heterogeneous, inherited connective tissue disorder frequently caused by abnormalities of type I collagen. It is characterized by bone fragility, osteopenia, and progressive skeletal deformities. Electron microscopy of three OI type II fetal bone samples revealed numerous large osteocyte lacunae. In addition, there was a perilacunar osteoid-like band of collagen surrounding the osteocytes, which was unmineralized and morphologically unusual. Furthermore, large osteocyte lacunae contained fine particles and filamentous material similar to the expected ultrastructural appearance of proteoglycans. More detailed examination was carried out using histochemical and immunogold localization of proteoglycans at light and ultrastructural levels. These tests and the use of electron probe X-ray microanalysis confirmed that the material in the osteocyte lacunae was proteoglycan. In contrast, in the age- and site-matched normal fetal bone, all the osteocyte lacunae appeared negative for proteoglycan. Proteoglycans are regarded as inhibitors of calcification. Our observation of substantial amounts of proteoglycan in abnormally enlarged osteocytic lacunae of some OI fetal bone suggests association with the abnormal bone of this particular subtype of OI type II.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8661486     DOI: 10.1007/bf02509444

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  34 in total

1.  A histochemical study of long bones in osteogenesis imperfecta congenita.

Authors:  A T SPENCER
Journal:  J Pathol Bacteriol       Date:  1962-04

2.  An electron microscopic study on the presence of proteoglycans in the mineralized matrix of rat and human compact lamellar bone.

Authors:  Y M Sauren; R H Mieremet; C G Groot; J P Scherft
Journal:  Anat Rec       Date:  1992-01

3.  Osteogenesis imperfecta: a histometric analysis.

Authors:  K A Falvo; P G Bullough
Journal:  J Bone Joint Surg Am       Date:  1973-03       Impact factor: 5.284

4.  Divergent and co-localization of the two small proteoglycans decorin and proteoglycan-100 in human skeletal tissues and tumors.

Authors:  A Bosse; K Schwarz; E Vollmer; H Kresse
Journal:  J Histochem Cytochem       Date:  1993-01       Impact factor: 2.479

5.  An electron microscopical study on the presence of proteoglycans in the calcified bone matrix by use of cuprolinic blue.

Authors:  Y M Sauren; R H Mieremet; C G Groot; J P Scherft
Journal:  Bone       Date:  1989       Impact factor: 4.398

6.  Osteogenesis imperfecta. Microradiographic and biochemical studies with special reference to the mucopolysaccharides (glycosaminoglycans).

Authors:  K Solheim
Journal:  J Oslo City Hosp       Date:  1969-12

7.  Effects of differences in mineralization on the mechanical properties of bone.

Authors:  J D Currey
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1984-02-13       Impact factor: 6.237

8.  Mechanisms of proteoglycan inhibition of hydroxyapatite growth.

Authors:  C C Chen; A L Boskey
Journal:  Calcif Tissue Int       Date:  1985-07       Impact factor: 4.333

9.  Osteogenesis imperfecta: an expanding panorama of variants.

Authors:  D Sillence
Journal:  Clin Orthop Relat Res       Date:  1981-09       Impact factor: 4.176

10.  Biochemical and immunocytochemical characterization of mineral binding proteoglycans in rat bone.

Authors:  M Takagi; M Maeno; A Kagami; Y Takahashi; K Otsuka
Journal:  J Histochem Cytochem       Date:  1991-01       Impact factor: 2.479

View more
  2 in total

Review 1.  The biology of osteocytes.

Authors:  Giolanta Kogianni; Brendon S Noble
Journal:  Curr Osteoporos Rep       Date:  2007-06       Impact factor: 5.096

2.  A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders.

Authors:  Sanne Treurniet; Elisabeth M W Eekhoff; Felix N Schmidt; Dimitra Micha; Björn Busse; Nathalie Bravenboer
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-23       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.